| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 16, 2008
From the Department of Medicine (Neurology), Center for Cerebrovascular Disease, Center for Clinical Health Policy Research, Duke University and Durham VA Medical Centers, Durham, NC. * To whom correspondence should be addressed. E-mail: golds004{at}mc.duke.edu.
Abstract—Governmental actions affect our lives and the lives of our fellow citizens in a variety of ways. This is certainly true for both the conduct of biomedical research and the provision of medical care. Governmental policy-makers require accurate information upon which to base their decisions. Stroke researchers and clinicians are uniquely suited to provide the facts, figures and statistics to help these officials weigh alternative options, and need to become actively involved in the advocacy efforts of their professional organizations. Although written from the perspective of the United States, the issues raised are relevant throughout the world.
Revised on June 23, 2008
Accepted on July 16, 2008
Reducing Death and Disability From Stroke. The Role of Governmental Advocacy
Larry B. Goldstein MD, FAAN, FAHA*
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |